Insulin sensitivity in peripheral tissues (null)

Insulin sensitivity in peripheral tissues refers to the capacity of cells—primarily skeletal muscle, adipose tissue, and liver—to respond effectively to circulating insulin. This physiological property determines how efficiently these tissues take up glucose from the bloodstream following an increase in blood sugar levels. At the molecular level, insulin binds its receptor on cell surfaces, triggering a cascade involving insulin receptor substrates (IRS), PI3K/Akt/mTOR pathway, and downstream effectors that promote glucose transporter translocation and metabolic responses. Impaired insulin sensitivity—termed insulin resistance—is central to the pathogenesis of type 2 diabetes mellitus and is associated with obesity, cardiovascular disease, inflammation, and other chronic conditions. While many therapeutic agents aim to improve peripheral tissue response to insulin by targeting specific molecules within this pathway (such as PPARγ agonists), "insulin sensitivity in peripheral tissues" itself is a functional outcome rather than a discrete druggable target or single protein/receptor entity. Note: This entry does not correspond to a single canonical molecule or receptor but describes an integrated physiological property resulting from complex interactions among multiple proteins and pathways. For structured data purposes requiring individual druggable entities (e.g., receptors/enzymes), refer instead to components like "Insulin receptor," "Peroxisome proliferator–activated receptor gamma," etc.

Other names

Peripheral insulin sensitivityTissue insulin responsivenessInsulin action in peripheral tissues

Mechanisms involve modulation of insulin signaling pathways via receptors and intracellular mediators; drugs act on upstream targets like PPARγ or AMPK to enhance tissue response to insulin